Fidelity Investments’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-677,633
| Closed | -$11.3M | – | 2752 |
|
|
2017
Q3 | $11.3M | Sell |
677,633
-194,708
| -22% | -$3.17M | ﹤0.01% | 1896 |
|
|
2017
Q2 | $15.6M | Buy |
872,341
+719,541
| +471% | +$13.4M | ﹤0.01% | 1770 |
|
|
2017
Q1 | $3.06M | Buy |
+152,800
| New | +$3.56M | ﹤0.01% | 2266 |
|
|
2016
Q1 | – | Sell |
-76,800
| Closed | -$1.71M | – | 2790 |
|
|
2015
Q4 | $1.71M | Sell |
76,800
-557,700
| -88% | -$11.6M | ﹤0.01% | 2454 |
|
|
2015
Q3 | $10.8M | Sell |
634,500
-54,700
| -8% | -$851K | ﹤0.01% | 1921 |
|
|
2015
Q2 | $9.48M | Buy |
689,200
+32,100
| +5% | +$427K | ﹤0.01% | 2030 |
|
|
2015
Q1 | $9M | Buy |
657,100
+304,800
| +87% | +$3.52M | ﹤0.01% | 2035 |
|
|
2014
Q4 | $3.72M | Buy |
+352,300
| New | +$4.17M | ﹤0.01% | 2310 |
|
|
2014
Q3 | – | Sell |
-51,000
| Closed | -$698K | – | 2864 |
|
|
2014
Q2 | $698K | Buy |
+51,000
| New | +$667K | ﹤0.01% | 2553 |
|
Fidelity Investments's OME Position: Q4 2017 in Review
Fidelity Investments sold out of Omega Protein (OME) in Q4 2017, closing a stake of 677,633 shares — an estimated $11.3M sold.
Fidelity Investments first reported a position in OME in Q2 2014 and held it in 9 quarters. The position peaked at $15.6M in Q2 2017. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- Fidelity Investments reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- Fidelity Investments sold 677,633 Omega Protein shares in Q4 2017, an estimated $11.3M.
- Fidelity Investments first reported a position in Omega Protein in Q2 2014 and held it in 9 quarters.
- Fidelity Investments's Omega Protein position peaked at $15.6M in Q2 2017.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on Fidelity Investments's 13F filing for Q4 2017, filed 12 Feb 2018.